CymaBay Therapeutics (CBAY) Competitor Comparison
We are evaluating the key criteria listed to compare CymaBay Therapeutics (CBAY) against its competitors in the Biotechnology industry.
Market Capitalization
50 / 368Gross Profits
189 / 278Total Revenue
142 / 300EBITDA
180 / 337Free Cashflow
212 / 352Quick Ratio
19 / 357Earnings per Share
135 / 359Dividend yield
0 / 6Total Cash
71 / 358Performance 3 years
9 / 368Performance 5 years
44 / 368Performance 10 years
27 / 368Linearity 3 years
357 / 368Linearity 5 years
355 / 368Linearity 10 years
342 / 367Total Rank
102 / 368Dividend Rank
103 / 368Valuation Rank
290 / 368Piotroski Rank
17 / 368Muliplier Rank
325 / 368Market Capitalization - CBAY ranking 50 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.